Aug 18 (Reuters) – The U.S. Food and Drug Administration has
widened the use of Edwards Lifesciences Corp’s heart
valves to patients at intermediate risk of complications if they
underwent open heart…
The post FDA widens use of Edwards’ devices for heart valve replacement appeared first on NASDAQ.